Health Sciences Acquisiti...

NASDAQ: HSAQ · Real-Time Price · USD
13.31
2.59 (24.16%)
At close: Jan 26, 2023, 9:59 PM

Health Sciences Acquisitions 2 Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
2.64M n/a n/a
Cost of Revenue
204K n/a n/a
Gross Profit
2.43M n/a n/a
Operating Income
-64.3M -3.08M -394.76K
Interest Income
n/a 345.14K 16K
Pretax Income
-61.02M -2.74M -378.75K
Net Income
-61.02M -2.39M -362.75K
Selling & General & Admin
23.93M 2.96M 274.76K
Research & Development
42.8M n/a n/a
Other Expenses
n/a n/a n/a
Operating Expenses
66.73M 2.96M 274.76K
Interest Expense
n/a -345.14K -16K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
66.94M 2.96M 274.76K
Income Tax Expense
n/a -345.14K -16K
Shares Outstanding (Basic)
36.82B 16.43M 20.27M
Shares Outstanding (Diluted)
36.82B 16.43M 20.27M
EPS (Basic)
-1.66 -0.15 -0.02
EPS (Diluted)
-1.66 -0.15 -0.02
EBITDA
-64.3M -2.74M -378.75K
EBIT
n/a -3.08M -394.76K
Depreciation & Amortization
n/a 345.14K 16K